1772-03-8Cl.N[C@@H](C=O)[C@@H](O)[C@@H](O)[C@H](O)COCBOJBBMQJBVCMW-NQZVPSPJSA-NSee also: D-Galactosamine (annotation moved to); aldehydo-D-galactosamine (annotation moved to).
Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
This chemical does not meet GHS hazard criteria for 88.9% (8 of 9) of all reports.
Warning
H319 (11.1%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
P264+P265, P280, P305+P351+P338, and P337+P317 (click each P-code to see the statement)
Aggregated GHS information provided per 9 reports by companies from 2 notifications to the ECHA C&L Inventory.
UsesD-(+)-Galactosamine (D-chondrosamine) is used with lipopolysaccharides (LPS) to induce models of acute hepatic failure (LPS/D-GalN-induced liver injury, hepatitis) for therapeutic research to find new drugs.
UsesD-(+)-Galactosamine hydrochloride has been used to:induce livery injury inflammatory liver injury acute liver failure (ALF) in mice
UsesSpecifically inhibits COX-2 by preventing COX-2 N-glycosylation and by increasing COX-2 protein turnover in a proteasome-dependent manner.
General DescriptionPharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
No reaction records under the current filter.
Loading…
1772-03-8